SCHEMBL30272502

SCHEMBL30272502

N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O

nearest known ligand 0.36

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ MME P08473 1/20 0.34
▸ SLC15A2 Q16348 1/20 0.34
▸ CPB2 Q96IY4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29630312 1.00 MME (0.34) MMESLC15A2CPB2
SCHEMBL29590288 0.98 MME (0.36) MMESLC15A2
SCHEMBL29630315 0.98 MME (0.36) MMESLC15A2
SCHEMBL2132230 0.97 MME (0.36) MMECPB2
SCHEMBL30559586 0.97 MME (0.36) MMECPB2
SCHEMBL2132240 0.97 MME (0.36) MMECPB2
SCHEMBL29777856 0.96 MME (0.39) MMESLC15A2CPB2
SCHEMBL29471298 0.95 MME (0.38) MMESLC15A2CPB2
SCHEMBL31113501 0.93 BACE1 (0.35) —
SCHEMBL29461560 0.93 MME (0.39) MME

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11628202-B2 Methods of reducing the need for surgery in patients suffering from benign prostatic hyperplasia NYMOX CORPORATION (CA) 2023-04-18 — — US disclosed
Send feedback